Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna Oechtering

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Modulator of VRAC Current 1 Is a Potential Target Antigen in Multiple SclerosisJohannes Raffael Dahl, Alicia Weier, Christopher Winter, et al.
European Journal of Neurology|February 1, 2022
Spinal cord gray matter atrophy is associated with functional decline in post-polio syndromeMaria Janina Wendebourg, Matthias Weigel, Laura Richter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2020
Monitoring of radiologic disease activity by serum neurofilaments in MSTomas Uher, Sabine Schaedelin, Barbora Srpova, et al.
Journal of Neuroinflammation|May 2, 2021
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorderPatrick Schindler, Ulrike Grittner, Johanna Oechtering, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2023
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosisDavid Leppert, Mitsuru Watanabe, Sabine Schaedelin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 13, 2026
Serum Glial Fibrillary Acidic Protein and Retinal Neuronal Loss as Additive Prognostic Markers of Disability in Multiple SclerosisShaumiya Sellathurai, Kean Schoenholzer, Federico Burguet Villena, et al.
The Lancet. Neurology|July 31, 2023
Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation studyAhmed Abdelhak, Franziska Petermeier, Pascal Benkert, et al.
Brain : a Journal of Neurology|December 20, 2023
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5Ilaria Callegari, Johanna Oechtering, Mika Schneider, et al.
Journal of Clinical Lipidology|August 8, 2020
Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosisMason McComb, Maggie Krikheli, Tomas Uher, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2025
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activitySofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Modulator of VRAC Current 1 Is a Potential Target Antigen in Multiple SclerosisJohannes Raffael Dahl, Alicia Weier, Christopher Winter, et al.
European Journal of Neurology|February 1, 2022
Spinal cord gray matter atrophy is associated with functional decline in post-polio syndromeMaria Janina Wendebourg, Matthias Weigel, Laura Richter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2020
Monitoring of radiologic disease activity by serum neurofilaments in MSTomas Uher, Sabine Schaedelin, Barbora Srpova, et al.
Journal of Neuroinflammation|May 2, 2021
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorderPatrick Schindler, Ulrike Grittner, Johanna Oechtering, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2023
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosisDavid Leppert, Mitsuru Watanabe, Sabine Schaedelin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 13, 2026
Serum Glial Fibrillary Acidic Protein and Retinal Neuronal Loss as Additive Prognostic Markers of Disability in Multiple SclerosisShaumiya Sellathurai, Kean Schoenholzer, Federico Burguet Villena, et al.
The Lancet. Neurology|July 31, 2023
Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation studyAhmed Abdelhak, Franziska Petermeier, Pascal Benkert, et al.
Brain : a Journal of Neurology|December 20, 2023
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5Ilaria Callegari, Johanna Oechtering, Mika Schneider, et al.
Journal of Clinical Lipidology|August 8, 2020
Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosisMason McComb, Maggie Krikheli, Tomas Uher, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2025
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activitySofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, et al.
Pageof 6